Karolinska Development's portfolio company Promimic has formed a new partnership with the U.S company Onkos Surgical to commercialize Promimic's proprietary Hydroxyapatite (HA) Surface Technologies in Limb Salvage Surgery.
Promimic develops and markets products within nano- materials for innovative surface treatments and has developed the HAnano Surface that is clinically proven to speed up and improve the anchoring of implants in bone. The innovative technology is already licensed to several dental implant companies. The partnership with Onkos Surgical[R], a U.S company addressing the clinical challenges associated with tumor surgery, represents an important step into the orthopaedic space.
The partnership will focus on combining Promimic's HAnano Surface Technology with Onkos Surgical's ELEOS Limb Salvage Portfolio. Implant failure due to aseptic loosening remains one of the key challenges associated with limb salvage surgery. With HAnano Surface, Onkos Surgical[R] aims to develop implants with a porous coated ingrowth structure and thin layered HA.
"We are happy to see that Onkos Surgical acknowledges the potential in the highly advanced technology that our portfolio company Promimic offers. This further strengthens Promimic's position as a value creating partner for high profiled orthopedic implant companies", said Viktor Drvota, CEO of Karolinska Development.
About Karolinska Development AB
Karolinska Development AB (Nasdaq Stockholm: KDEV) is a Nordic life sciences investment company. The company focuses on...